Marksans Pharma Share Price in Focus; To Acquire Germany-Based ABCnow GmbH to Expand European Presence

Marksans Pharma Limited has entered into a definitive agreement to acquire 100% of the share capital of ABCnow GmbH, a pharmaceutical wholesale and distribution company based in Germany, as per the exchange filings. 

The acquisition marks a strategic step in strengthening the company's presence across regulated European markets while expanding its forward-integration strategy through direct market access in the European Union.  

Acquisition Strengthens European Footprint 

Marksans Pharma will acquire the entire shareholding of ABCnow GmbH for €892,384 through a cash transaction. The acquisition is expected to be completed by 31 July 2026. 

The acquisition will enable Marksans Pharma to utilise ABCnow's front-end sales and marketing infrastructure to market products manufactured in India, the United Kingdom and the United States. 

It will also establish the company's own front-end presence in Germany, enhancing direct access to customers and strengthening its position across European pharmaceutical markets.  

Strategic Expansion in Europe 

The transaction supports Marksans Pharma's strategy of building direct commercial capabilities in regulated international markets rather than relying solely on third-party distribution. 

By integrating ABCnow's sales and distribution network, the company aims to strengthen its European operations while expanding the reach of products manufactured across its global facilities.  

About ABCnow GmbH 

ABCnow GmbH is a Germany-based pharmaceutical wholesale and distribution company headquartered in Flensburg. Incorporated in 2023, it primarily markets and distributes over-the-counter (OTC) pharmaceutical products in the German market. 

The company reported revenue of €510,215.60 in 2024 and €227,233.69 in 2025. According to Marksans Pharma, ABCnow's experienced professional team is expected to support its long-term growth plans in Germany. 

Read More: Top 2 Performing Pharma and Healthcare Mutual Funds with Over 20% Annualised Returns in 2 Years! 

Marksans Pharma Share Price Performance  

As of 08 July 2026, at 12:53 PM, Marksans Pharma Limited share price was trading at ₹266.90 per share, reflecting a surge of 2.18% from the previous trading session. 

Conclusion 

The acquisition of ABCnow GmbH strengthens Marksans Pharma's presence in Germany and supports its broader expansion across regulated European markets. The deal also provides the company with direct sales and distribution capabilities to support future growth in the region.  

Want to read stock market updates in Hindi? Angel One News gives comprehensive share market news in Hindi.  

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.  

Investments in the securities market are subject to market risks, read all the related documents carefully before investing. 

Take action on today’s market news - Complete your Demat Account Opening now.